Atherosclerosis as a Risk Factor of Inflammatory Bowel Disease: A Population-Based Case-Control Study

Author:

Faye Adam S.1,Axelrad Jordan E.1ORCID,Sun Jiangwei2ORCID,Halfvarson Jonas3ORCID,Söderling Jonas4,Olén Ola456ORCID,Ludvigsson Jonas F.278ORCID

Affiliation:

1. Inflammatory Bowel Disease Center at NYU Langone Health, Division of Gastroenterology, Department of Medicine, NYU School of Medicine, New York, New York, USA;

2. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden;

3. Department of Gastroenterology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden;

4. Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden;

5. Sachs' Children and Youth Hospital, Stockholm South General Hospital, Stockholm, Sweden;

6. Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden;

7. Department of Pediatrics, Örebro University Hospital, Örebro, Sweden;

8. Division of Digestive and Liver Disease, Department of Medicine, Columbia University Medical Center, New York, New York, USA.

Abstract

INTRODUCTION: Data suggest atherosclerotic-related inflammation may play a role in the pathogenesis of inflammatory bowel disease (IBD), but large-scale studies are missing. METHODS: In this nationwide case-control study, we used the Swedish Patient Register and the Epidemiology Strengthened by histoPathology Reports in Sweden cohort to identify adult cases of incident IBD between 2002 and 2021, with each case matched to up to 10 general population controls. We used conditional logistic regression to calculate odds ratios (OR) for exposure to an atherosclerotic-related condition (myocardial infarction, thromboembolic stroke, or atherosclerosis itself) before being diagnosed with IBD. RESULTS: There were a total of 56,212 individuals with IBD and 531,014 controls. Of them, 2,334 (4.2%) cases and 18,222 (3.4%) controls had a prior diagnosis of an atherosclerotic-related condition, corresponding to an OR of 1.30 (95% confidence interval [CI] 1.24–1.37). Results were statistically significant for both Crohn's disease (OR 1.37, 95% CI 1.26–1.48) and ulcerative colitis (OR 1.27, 95% CI 1.20–1.35) and for individuals who developed IBD at 40–59 years of age and 60 years or older. In addition, associations persisted when adjusting for underlying comorbidities, including the presence of immune-mediated diseases and prior aspirin and/or statin use. The highest odds of an atherosclerotic-related condition were seen in the 6–12 months before IBD diagnosis, though odds were increased even ≥5 years before. A higher magnitude of odds was also observed when having 2 or more atherosclerotic-related conditions when compared with having only 1 condition. DISCUSSION: A history of an atherosclerotic-related condition is associated with increased odds of developing IBD, particularly among older adults. Future studies should investigate whether drugs targeting atherosclerotic-related inflammation may prevent IBD in higher-risk individuals.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3